The record
Written from the 1 report below. Nothing here is unsourced.
- India has secured access to the Qdenga dengue vaccine, which is expected to be available for public use by the first half of 2027.
- This follows a partnership agreement between the Indian company Dr.
- Reddy's Laboratories and the Japanese firm Takeda Pharmaceutical.
- The vaccine, which received marketing approval from Indian drug regulatory authorities last July, is considered highly effective in preventing dengue.
Coverage1
1 report
Indian-language1
All filed from India
Named India · Japan · IN-KA · Central Drugs Standard Control Organisation · Dr Reddy's Laboratories · QDENGA · Takeda Pharmaceutical
The 1 report is listed beside the record.
Ask this story
Answers cite the reports above, or say they can't.